Eminence Organics
DECEMBER 24, 2024
Best Skin Care For A Dry Climate Written By (old): Thea Christie Do you live in an arid or desert climate and it's making your skin dry? If youve ever wondered what happens to our skin when there is a lack of humidity in the atmosphere, were here to explain. Whether you live in such an environment, or you notice skin changes when you travel, there are good reasons as to why your skin is acting up.
CAMEO College - Beauty News
DECEMBER 21, 2024
As we step into 2024, the journey of personal development continues to be a vital focus for many individuals. Confidence. The post 10 Confidence Podcasts to Boost Your Motivation in 2024 first appeared on Cameo College of Essential Beauty.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Dermatology Times
DECEMBER 26, 2024
As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in aesthetic/cosmetic dermatology this year.
The Dermatology Digest
DECEMBER 24, 2024
Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, IL, reviews the latest efficacy and safety data on oral and topical Janus kinase (JAK) inhibitors used in dermatology. He spoke on this topic at the 2024 Revolutionizing Atopic Dermatitis (RAD) Conference. The post Important Updates on the Efficacy and Safety of JAK Inhibitors in Dermatology appeared first on The Dermatology Digest.
Alison Bladh
DECEMBER 23, 2024
Discover How to Navigate Midlife Health with Confidence Are you feeling overwhelmed by the changes of perimenopause and menopause? Youre not alone but it doesnt have to be this way! I joined Rachael Vassar on her Experience Health podcast to discuss how women can not only survive but thrive during this transformative phase of life. As a Registered Nutritional Therapist and Esthetician with decades of experience, I shared advanced strategies to support your hormonal health, manage common symptoms
US Dermatologt Partners
DECEMBER 23, 2024
Melanoma is a serious form of skin cancer, and early detection is crucial since treatment is more likely to be successful for early-stage melanoma. According to Dr. Arianna Yanes , MD, FAAD of U.S. Dermatology Partners in Annapolis , The common signs of melanoma are referred to as the A, B, C, D, Es. This stands for Asymmetry, Border irregularity, Color variation, large Diameter, and Evolving over time.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
The Dermatology Digest
DECEMBER 27, 2024
Johnson & Johnson has entered into an exclusive licensing agreement for the global development, manufacturing and commercialization of a STAT6 program for autoimmune and allergic diseases, including atopic dermatitis (AD), from Kaken Pharmaceutical. Johnson & Johnson gains an exclusive license to Kakens STAT6 program, including lead candidate KP-723.
West Lake Dermatology
DECEMBER 24, 2024
Acne scars can linger long after active breakouts have healed, leaving many people feeling frustrated with their skins appearance. These scars come in various forms, from shallow depressions to deep, tethered scars that alter the skins texture. For those dealing with persistent acne scars, subcision has emerged as an effective treatment, particularly for more severe forms of acne scarring.
Lydia Sarfati
DECEMBER 23, 2024
90-minute interactive virtual business class with Repchage Founder and CEO Lydia Sarfati. Live Presentation – January 20th, 2025 – 12 pm to 1:30pm Already A Member? SIGN IN VIRTUAL MASTER CLASS: Dermaplaning with Red-Out Facial 90-minute interactive virtual business class with Repchage Founder and CEO Lydia Sarfati. Live Presentation – January 20th, 2025 – 12 pm to 1:30pm SIGN UP $20.00 Monthly Access Month long access to live Academy courses as well access to library of
Dermatology Times
DECEMBER 23, 2024
Hidradenitis suppurativa requires clinical vigilance, empathy, and the courage to escalate therapy early.
Texas Dermatology
DECEMBER 24, 2024
If youve already decided on laser hair removal and want to ensure the best results, understanding aftercare is essential. Laser hair removal works by safely targeting hair follicles with laser energy, destroying them to leave your skin smooth, supple, and hair-free. To help you maximize your results, Texas Dermatology is sharing the top 3 tips for effective laser hair removal aftercare.
The Dermatology Digest
DECEMBER 23, 2024
Biofrontera Inc. has installed the 100 th commercial RhodoLEDXL Lamp in the U.S. market. The RhodoLED XL was approved by the U.S. Food and Drug Administration (FDA) for use in combination with aminolevulinic acid HCl (Ameluz) in 2022 and was launched in June 2024. Ameluz is used in combination with photodynamic therapy using BF-RhodoLED or RhodoLED XL lamp for the lesion-directed and field-directed treatment of actinic keratoses of mild to moderate severity on the face and scalp.
Fairlawn Aesthetic MD
DECEMBER 26, 2024
Musculoskeletal pain and injuries are not just inconvenient; they can seriously impact your quality of life. Imagine dealing with persistent back pain that hampers your daily activities or knee pain that limits your mobility. When faced with such challenges, finding a significant and long-lasting solution becomes essential. This is where OrthoGold Shockwave Therapy steps in as a revolutionary, non-invasive treatment for musculoskeletal pain and injuries.
Dermatology Times
DECEMBER 27, 2024
Catch up on coverage of FDA-approved drugs in the second half of 2024.
Texas Dermatology
DECEMBER 23, 2024
If you are ready to start laser hair removal, you may be curious about the preparation process. Proper preparation minimizes the risk of irritation, enhances the lasers ability to target hair follicles, and helps achieve optimal results in fewer sessions. Additionally, understanding what to avoidlike sun exposure or certain skincare productscan prevent unwanted complications and ensure their skin is in the best condition for treatment.
Renee Rouleau
DECEMBER 27, 2024
While social media (especially TikTok) is a great tool for spotting trends, they can come and go so quickly, hence why its called a trend. I prefer to rely on other sources, like information Im hearing from my skincare labs and trusted chemists, as well as all of the conferences I attended this past year where the best and brightest skincare professionals gather to share information.
Cosmetify
DECEMBER 27, 2024
Introduction to JeetBuzz Bangladesh JeetBuzz has rapidly gained popularity in Bangladesh as a premier online platform for both sports betting and casino gaming. Offering a wide range of betting options, competitive odds, and a secure, user-friendly environment, JeetBuzz has become a go-to choice for sports enthusiasts and casino players alike. Whether you are interested in betting on your favorite sports, spinning the reels in exciting slot games, or playing classic table games, Jeetbuzz Login p
Dermatology Times
DECEMBER 27, 2024
Catch up on Dermatology Times conference coverage from January through June of this year.
US Dermatologt Partners
DECEMBER 25, 2024
Skin Manifestations of Breast Cancer: Cautions for the Dermatology Clinician Having declined slightly in the early 2000s, the rate of new female breast cancer cases has ticked up each year from 2014 to 2019, according to the CDC. And while the number of breast cancer deaths has been relatively stable for the last 2 decades, the death rate has decreased from 26.6 per 100,000 in 1999 to 19.4 per 100,000 in 2019.
Dermatology Times
DECEMBER 27, 2024
As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in atopic dermatitis this year.
Dermatology Times
DECEMBER 26, 2024
Catch up on coverage of FDA-approved drugs in the first half of 2024.
Dermatology Times
DECEMBER 26, 2024
As 2023 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in psoriasis this year.
Dermatology Times
DECEMBER 25, 2024
As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in vitiligo this year.
Dermatology Times
DECEMBER 24, 2024
Dermatology Times is looking back on the top dermatology news headlines from 2024.
Dermatology Times
DECEMBER 24, 2024
Deucravacitinib achieved ACR20 response in PsA patients at Week 16, with a safety profile consistent with previous studies.
Dermatology Times
DECEMBER 23, 2024
As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in prurigo nodularis this year.
Dermatology Times
DECEMBER 23, 2024
These promising results align with what was discovered in the single-ascending dose portion of the trial earlier this year.
Dermatology Times
DECEMBER 23, 2024
Dermatology Times is looking back on the top stories in dermatology that involve strides in skin health equity: addressing disparities for skin of color, women, LGBTQ+ patients, and improving care access.
Dermatology Times
DECEMBER 23, 2024
As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in rosacea this year.
Dermatology Times
DECEMBER 22, 2024
As 2024 comes to a close, Dermatology Times is taking a look back at the studies, treatment, and advances in chronic hand eczema this year.
Dermatology Times
DECEMBER 21, 2024
In case you missed it, this week we had news about tapinarofs FDA approval in AD patients 2 and older, new ICD-10 codes for CCCA and FFA, a phase 2 study of INF904, and more.
Dermatology Times
DECEMBER 27, 2024
Explore the top dermatology news of 2024, highlighting breakthroughs, innovations, and key clinical insights shaping the future of skin care and treatment.
Dermatology Times
DECEMBER 24, 2024
James Song, MD, FAAD, discusses how recent advancements in atopic dermatitis treatment include targeted biologics and Janus kinase inhibitors that offer promising alternatives to traditional therapies for patients with moderate-to-severe disease.
Dermatology Times
DECEMBER 24, 2024
A panelist discusses how the current treatment options for atopic dermatitis range from topical corticosteroids and calcineurin inhibitors for mild cases to systemic medications such as dupilumab and Janus kinase inhibitors for moderate-to-severe disease, with selection based on factors such as disease severity, patient age, and safety considerations.
Expert insights. Personalized for you.
79 
Let's personalize your content